Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
PFAS, synthetic chemicals found in many common products, may be contributing to an increase in liver problems, such as fatty liver disease.
Higher daily alcohol consumption was linked to greater risk for MAFLD.
The higher risk for women with longer periods does not appear to be related to obesity.
Liver fat reduction was similar with high-intensity interval exercise and moderate-intensity continuous training.
Latino individuals are at higher risk for NAFLD, but Black people with NAFLD are more likely to develop cirrhosis.
More than half of individuals with post-COVID illness showed signs of MAFLD.
Noninvasive imaging may be the best way to screen for NAFLD in this population.
Intensive lifestyle management led to weight loss and reduced steatosis and fibrosis.
Abdominal obesity worsened the impact of air pollution on MAFLD development.
Fatty liver disease dominated the Hep science news this year, but COVID-19 remains a concern for people with liver disease.
People with fatty liver disease and obesity who underwent bariatric surgery had better clinical outcomes.
Even with this increase, older individuals now have better transplant outcomes.
People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.
Research has shown that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of HCC.
Advanced stages of NAFLD were more commonly seen in people whose mothers had obesity or overweight during pregnancy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.